Foley Advises AST SpaceMobile in Combination with New Providence Acquisition Corp.

12 April 2021 Media Contact: Jen Dilworth News

Foley & Lardner LLP acted as co-legal counsel to AST SpaceMobile, Inc. – the company building the first and only space-based cellular broadband network accessible directly by standard mobile phones – in its combination with New Providence Acquisition Corp. As of April 7, 2021, AST SpaceMobile’s Class A common stock and warrants started trading on NASDAQ under the symbols “ASTS” and “ASTSW.”

AST SpaceMobile’s service offering addresses a $1 trillion global mobile wireless market. Once implemented, its services will eliminate the connectivity gaps experienced by billions of mobile subscribers and bring cellular broadband to almost half the world’s population who are unconnected. This will be accomplished in collaboration with mobile network operators and wireless infrastructure companies like Vodafone Group, Rakuten and American Tower.

AST SpaceMobile received $462 million in gross proceeds from the transaction, consisting of New Providence’s approximately $232 million cash in trust and roughly $230 million from a PIPE investment, including investments from Rakuten, Vodafone, American Tower and UBS O’Connor.

The Foley team was led by partners Paul Broude, David Kantaros and John Wolfel, with support from senior counsels Von Bryant and Garrett Bishop and associate Jasmine Joseph.

Related Services


Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream